Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.750
0.00 (0.00%)
Mar 3, 2026, 9:30 AM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $267.58 million as of March 4, 2026. Its market cap has increased by 17.09% in one year.
Market Cap
267.58M
Enterprise Value
165.57M
Revenue
25.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.75
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 267.58M, a decrease of -50.30%. That is a compound annual growth rate of -11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 267.58M | -6.83% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 361.40M |
| CytoDyn | 296.04M |
| Vaxart | 180.09M |
| BioStem Technologies | 90.09M |
| HST Global | 70.56M |
| Nuo Therapeutics | 67.60M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |